• Section 1: Discussion about the molecular pathways that have been identified in different RCC subtypes.
    • Section 2: Review what is known about the molecular underpinnings of papillary RCC.
    • Section 3: Characterize histologic features and molecular alterations in sporadic cases that were originally diagnosed as pRCC, type 2 or high-grade pRCC.
Session date: 
06/26/2026 - 12:00pm to 1:00pm CDT
Add to calendar: 
  • 1.00 ABPath Lifelong Learning
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Dr. Melissa Tjota & Dr. Peng Wang